10X Genomics is a biotechnology company that specializes in genomic analysis, providing tools and technologies for researchers in the life sciences sector
The company develops innovative products that enable high-resolution analysis of biological systems, allowing scientists to explore complex interactions at the single-cell level. By offering advanced sequencing and gene expression solutions, 10X Genomics supports a wide range of applications in genomics, transcriptomics, and immunology, aiming to accelerate the discovery of new insights into health and disease.
10x Genomics reported Q3 2024 revenue of $151.7 million, down 1% from last year. Instruments revenue dropped 46%, while consumables grew 10%. CEO Serge Saxonov acknowledged the challenges faced but remains confident in future growth.
The imminent release of the September consumer price inflation report is keeping sentiment guarded as the index futures trade modestly lower early Thursday.
